글로벌 마이크로어레이 시장 – 2029년까지의 산업 동향 및 예측

글로벌 마이크로어레이 시장 분석 및 규모

최근 몇 년 동안 마이크로어레이는 바이러스 및 유전적 질환 진단 , 약물 개발, 약물유전체학 연구, 암 진단 및 법의학적 응용 분야에서 점점 더 인기를 얻고 있습니다. 결과적으로 다양한 성장 결정인자의 존재는 예상 기간 동안 시장의 상당한 성장으로 이어집니다.

• 글로벌 마이크로어레이 시장은 2021년에 3,407.66백만 달러로 평가되었으며, 2029년까지 8,995.4백만 달러에 도달할 것으로 예상되며, 2022-2029년에 12.90%의 CAGR을 기록할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

글로벌 마이크로어레이 시장 정의

마이크로어레이는 여러 유전자의 발현을 동시에 검출하기 위한 최첨단 분자 생물학 기술입니다. 분석 설계는 빠르고 정확하며 비용 효율적이며 간단합니다. 마이크로어레이는 DNA, RNA, 단백질, 효소, 탄수화물 및 조직을 포함한 광범위한 미세 분자를 연구하는 데 사용할 수 있습니다. 유전자 발현 프로파일링, 분자 상호 작용, 바이오마커 프로파일링, 효소 활동, 경로 식별 및 돌연변이는 모두 가능한 응용 분야입니다. 마이크로어레이는 임상 연구 및 진단 및 기초 연구에 사용되고 있습니다.

보고 범위 및 시장 세분화

Microarray Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

• Growing Burden Of Diseases

The high frequency of cancer and the rising prevalence of various chronic diseases as well as the utilization of this approach to identify infectious diseases are driving the market forward. This is the most significant factor driving the growth for this market.

• High Usage for Various Applications

The usage of microarrays for numerous applications such as genotyping, forensic analysis, measuring predisposition to disease, evaluating somatic mutations in cancers or germline mutations in individuals, assessing loss of heterozygosity, among others are also expected to accelerate the overall growth of the market.

Furthermore, the expanding healthcare sector, increase in government funding for the healthcare sector, and the development in genetics are also expected to fuel market growth within the forecasted period. The rapidly evolving information and software technology as well as emerging bioinformatics, are also projected to bolster the growth of the market.

Opportunities

• Growing Advancements in Treatment

The advancement of diagnosis and treatment options has resulted in the development of goods that can assist patients in a wide range of situations, further offering numerous growth opportunities for the market.

• Surging Research and Funding Activities

There has been an increase in healthcare research and development, as there is a rising need for research in the pharmaceutical and healthcare industry. Therefore, the increase in genomic and proteomic research funding is also estimated to generate lucrative opportunities for the market.

Restraints/Challenges Global Microarray Market

• Requirement Of High-Tech Instruments 

On the other hand, the microarray basically requires high-tech instruments, which are very costly. Additionally, the cost of tests is also very high, which is expected to obstruct market growth.

• Availability of Substitutes

The availability of substitutes and the presence of alternate mediums for the analysis are estimated to impede the market's overall growth.

Also, the need for standardization of databases along with the shortage of skilled professionals are projected to challenge the microarray market in the forecast period of 2022-2029.

This microarray market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the microarray market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post Covid-19 Impact on Microarray Market

The microarray market was positively impacted by the outbreak of COVID-19. The rise in cases around the world has largely increased the vaccine research and development during Covid-19. As a result, prominent firms have launched a slew of new products to test immune surveillance, diagnostics, and vaccines. JPT Peptide Technologies (JPT) launched a set of ready-to-use peptide tools in April 2020 to analyze and profile the immune response to SARS-CoV-2 infection. The UC Irvine Vaccine R&D Center has also created a mechanism to evaluate COVID-19 protection against 34 coronavirus antigens, or 33 antigens. However, the disruption of the supply chain has made it difficult for microarray providers to obtain prepared microarray in time to fulfill the rising demand of populations. The research institution's routine operations have been delayed due to the lockdown. But the rising demand for testing and research is expected to rise as microarray technology becomes more widely used and as the number of patients suffering from various diseases rises, which will push the market's growth on a large scale.

Recent Developments

• In June 2020, Thermo Fisher Scientific launched the Axiom Human Genotyping SARS-CoV-2 Research Array, which will help epidemiologists to study the SARS-CoV-2 infectious disease.
• In April 2020, Celsee, Inc., a firm that provides instruments and consumables for the separation, detection, and analysis of single cells, has been bought by Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products. The acquisition's terms were not disclosed. During Bio-first-quarter Rad's 2020 financial results conference call, the company will go over the purchase in greater detail.

Global Microarray Market Scope

The microarray market is segmented on the basis of product, type, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Consumables
• Software
• Instruments

On the basis of product, the microarray market is segmented into consumables, software and instruments.

Type

• DNA
• Protein
• Other

On the basis of type, the microarray market is segmented into DNA, protein and others.

Application

• Research
• Drug Discovery
• Disease Diagnostics

On the basis of application, the microarray market is segmented into research, drug discovery and disease diagnostics.

End User

• Research and Academic Institutes
• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories
• Others

On the basis of end user, the microarray market is bifurcated into research and academic institutes, pharmaceutical and biotechnology companies, diagnostic laboratories and others.

Microarray Market Regional Analysis/Insights

The microarray market is analyzed and market size insights and trends are provided by country, product, type, application and end user as referenced above.

The countries covered in the microarray market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the microarray market because of the growing incidence of various diseases such as cancer and genetic diseases coupled with the increasing funding for genomics and proteomics research within the region.

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government funding for the healthcare sector, the growing geriatric population, and the increasing prevalence of chronic diseases and cancer within the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The microarray market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for microarray market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the microarray market. The data is available for historic period 2010-2020.

Competitive Landscape and Microarray Market Share Analysis

The microarray market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to microarray market.

Some of the major players operating in the microarray market are

• Thermo Fisher Scientific, Inc. (U.S.)
• Agilent Technologies, Inc. (U.S.)
• Molecular Devices, LLC (U.S.)
• PerkinElmer Inc. (U.S.)
• EKF Diagnostics (UK)
• Illumina, Inc. (U.S.)
• General Electric (U.S.)
• Bio-Rad Laboratories Inc. (U.S.)
• bioMérieux (France)
• BD (U.S.)
• Danaher (U.S.)
• Biosystems Inc., (U.S.)
• Luminex Corporation (U.S.)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Merck KGaA (Germany)
• Danaher (U.S.)

Research Methodology : Global Microarray Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

DBMR 연구팀이 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석, 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 남겨 산업 전문가에게 문의하세요  https://www.databridgemarketresearch.com/ko/speak-to-analyst/?dbmr=global-microarray-market

SKU-67990